Angiotensin Receptor Antagonists: all 1,100 studies that test it
Page 10 of 11. Open to participants first (75), then studies with results posted, then the rest; newest registration first within each.
- Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With HypertensionCompletedNCT00548067Phase 3
- CCB Safety Study in Treatment of Hypertension of ADPKDStatus unknownNCT00541853Phase 4
- A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive PatientsCompletedNCT00538486Phase 4
- Effect of the Angiotensin II Receptor Antagonist Irbesartan on Biochemical and Functional Markers of Endothelial Dysfunction in Patients With HypertensionCompletedNCT00529750Phase 4
- Losartan Therapy in Pulmonary HypertensionCompletedNCT00519870Phase 3
- Pathophysiological Mechanisms of Hypertensive LVH:Optimising RegressionCompletedNCT00518479Not applicable
- Left Atrial Remodelling in Hypertension: Effects of Ramipril or IrbesartanStatus unknownNCT00517322Phase 4
- Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on AmlodipineCompletedNCT00509470Phase 4
- Preventing Microalbuminuria in Type 2 DiabetesCompletedNCT00503152Phase 3
- Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate HypertensionCompletedNCT00500604Phase 4
- Preventing ESRD in Overt Nephropathy of Type 2 DiabetesCompletedNCT00494715Phase 3
- Telmisartan in Haemodialysis Patients With Chronic Heart FailureCompletedNCT00490958Phase 4
- Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 MonthsCompletedNCT00487123Phase 4
- HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)CompletedNCT00480805Phase 3
- Valsartan Optimal Therapy Against Elevated Home Blood Pressure Research（VOYAGER）StudyCompletedNCT00460213Phase 4
- Telmisartan and Renal Perfusion in Patients With Metabolic SyndromeCompletedNCT00452192Phase 3
- Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)CompletedNCT00446524Phase 3
- Irbesartan/Hydrochlorothiazide National Taiwan University Hospital ListingCompletedNCT00443612Phase 4
- The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential HypertensionCompletedNCT00438945Phase 4
- CHANCE - Candesartan in Hypertrophic CardiomyopathyStatus unknownNCT00430833Phase 2
- Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive PatientsCompletedNCT00426478Phase 4
- Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients HypertensionCompletedNCT00425997Phase 4
- Effects of Intensive Long-Term Vasodilation in Hypertensive Patients With Microvascular Angina PectorisTerminatedNCT00424801Not applicable
- Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS StudyCompletedNCT00421863Phase 4
- Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes MellitusCompletedNCT00419835Phase 4
- Supplemental Benefit of Angiotensin Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using OlmesartanCompletedNCT00417222Phase 3
- Bioavailability of Aliskiren and Valsartan as a Single Tablet vs. the Same Doses of the Two Drugs Given Separately to Healthy Subjects.CompletedNCT00416728Phase 1
- Bioavailability of Aliskiren and Valsartan Combined as a Single Tablet vs. the Same Medications Given Separately to Healthy Subjects.CompletedNCT00416468Phase 1
- To Compare the Blood Level of Marketed Japanese Valsartan Tablet Formulation vs Global Valsartan Tablet Formulation in Healthy VolunteersCompletedNCT00415883Phase 1
- The Effect of Eprosartan on Hormones and Kidney Function in Healthy Humans.CompletedNCT00409903Phase 4
- One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With HypertensionCompletedNCT00409851Phase 3
- Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive PatientsCompletedNCT00409643Phase 3
- Telmisartan and Losartan in Hypertensive IGTCompletedNCT00407862Phase 4
- Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in HypertensionCompletedNCT00400777Phase 4
- A Pharmacogenomic Study of Candesartan in Heart FailureCompletedNCT00400582Phase 4
- Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients (0954A-322)CompletedNCT00398541Phase 3
- Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic SyndromeCompletedNCT00394745Phase 3
- A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive PatientsCompletedNCT00392262Phase 3
- Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic SubjectsTerminatedNCT00388388Phase 2
- Efficacy and Safety of Valsartan and the Combination of Valsartan and SimvastatinCompletedNCT00385931Phase 3
- A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established AtherosclerosisCompletedNCT00382213Phase 3
- GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation RecurrenceCompletedNCT00376272Phase 3
- Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes MellitusTerminatedNCT00376181Phase 3
- Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and ProteinuriaSuspendedNCT00369538Phase 4
- Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus FelodipineCompletedNCT00367939Phase 3
- Pioglitazone and Losartan Provides Additional RenoprotectionCompletedNCT00364988Not applicable
- Olmesartan Medoxomil and Diabetic NephropathyCompletedNCT00362960Phase 3
- I PREVENT - Irbesartan In Hypertensive Diabetic PatientsCompletedNCT00362258Phase 4
- I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular HypertrophyCompletedNCT00362037Phase 4
- Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and NephropathyCompletedNCT00361023Not applicable
- Study of Optimal Treatment Plan in Hypertensives With Anti-AT1-Receptor AutoantibodyStatus unknownNCT00360763Phase 4
- Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus HydrochlorothiazideCompletedNCT00360178Phase 3
- Safety and Effects of Ramipril Combined With CandesartanCompletedNCT00356395Phase 4
- Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II HypertensionCompletedNCT00353912Phase 3
- Electrophysiological Effects of Irbesartan in Patients With Paroxysmal Atrial Fibrillation (AF)CompletedNCT00352560Phase 3
- Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current MonotherapyCompletedNCT00351130Phase 4
- Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II HypertensionCompletedNCT00350168Phase 3
- Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial FunctionsCompletedNCT00350038Phase 4
- Effect of Irbesartan on Insulin Sensitivity in Chronic Heart FailureCompletedNCT00347087Phase 4
- The Use of DIOVAN to Reduce Post-Cardioversion Recurrence of Atrial Fibrillation Trial (the DRAFT Trial)TerminatedNCT00343499Phase 4
- Long Term Study of VAH631 in Patients With Essential Hypertension (Extension From B1303 Study)CompletedNCT00338936Phase 3
- Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal InsufficiencyTerminatedNCT00338091Not applicable
- I SAVE - Irbesartan in Mild to Moderate Hypertensive PatientsCompletedNCT00335673Phase 4
- Irbesartan in Chinese Hypertensive Diabetics With MicroalbuminuriaCompletedNCT00334581Phase 4
- Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in HypertensionCompletedNCT00333489Phase 4
- Diabetes Type 1, Treatment Study Atacand/Placebo After Kidney BiopsyStatus unknownNCT00328302Phase 4
- 8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe HypertensionCompletedNCT00327587Phase 3
- A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on MonotherapyCompletedNCT00327145Phase 3
- Trial of Telmisartan 80 mg/HCTZ 12.5 mg and Telmisartan 40 mg/HCTZ 12.5 mg in Patients With HypertensionCompletedNCT00326768Phase 3
- Angiotensin II Antagonism of TGF-Beta 1CompletedNCT00320970Not applicable
- Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent MicroalbuminuriaCompletedNCT00320879Phase 4
- Clinical Trial to Assess the Effects of Candesartan on the Carbohydrate Metabolism of Obese SubjectsTerminatedNCT00319202Phase 4
- Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and HypercholesterolemiaCompletedNCT00316095Phase 3
- A Study of VAH631 in Patients With Essential Hypertension (Factorial Study)CompletedNCT00311740Phase 3
- Effects of Sodium Intake on (PK/PD) Relationship of a Single Dose of a Renin Angiotensin System-BlockerCompletedNCT00310778Phase 1
- Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport SyndromeCompletedNCT00309257Phase 2
- Safety and Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) Plus Valsartan in Patients With Kidney Transplants (MYTHOSCompletedNCT00308425Phase 3
- Effectiveness of a Valsartan Based Versus an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current MonotherapyCompletedNCT00304226Phase 4
- Comparison of the Antihypertensive Efficacy of Valsartan and Enalapril After Missing One DoseCompletedNCT00302705Phase 4
- Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis CCompletedNCT00298714Phase 4
- ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment ElevationCompletedNCT00296218Phase 3
- Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic StenosisStatus unknownNCT00294775Phase 3
- A Study of Valsartan Administered Once Daily Versus Twice Daily, in Patients With Stable, Chronic Heart FailureCompletedNCT00294086Phase 2
- Effectiveness of Candesartan and Telmisartan on Morning Hypertension in Japanese Obese PatientsStatus unknownNCT00288717Not applicable
- APROVE : Irbesartan in HypertensionCompletedNCT00283036Phase 4
- Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and PlaceboCompletedNCT00282178Phase 2
- Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of HypertensionCompletedNCT00281593Phase 3
- Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With HypertensionCompletedNCT00280540Phase 4
- Renal Protective Effect of ACEI and ARB in Primary HyperoxaluriaWithdrawnNCT00280215Phase 3
- Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With HypertensionCompletedNCT00277472Phase 4
- The Effects of Angiotensin II Receptor Blockade on Kidney Function and Scarring After Liver TransplantCompletedNCT00275639Phase 4
- PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)CompletedNCT00274638Phase 4
- Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPMCompletedNCT00274612Phase 4
- PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTNCompletedNCT00274599Phase 4
- Inflammation and Coronary Artery Disease: Role of AT1-Receptor AntagonismCompletedNCT00274144Phase 4
- DETAIL Study: Diabetes Exposed to Telmisartan and EnalaprilCompletedNCT00274118Phase 3
- SAFE-CRP: Structural Alterations and Function of Endothelium in Cardiovascular Risk PatientsTerminatedNCT00274105Phase 4
- Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe HypertensionCompletedNCT00273299Phase 3
- Open-label Follow-up Trial of Fixed Dose Combination of Telmisartan + Hydrochlorothiazide in Hypertensive PatientsCompletedNCT00267943Phase 3
- Irbesartan in HypertensionCompletedNCT00265967Phase 4